Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Dogs with dermatitis show significant skin changes and higher white blood cell counts.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Older skin has higher cancer risk due to inflammation and stem cell issues.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Researchers found four genes that could help diagnose severe alopecia areata early.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Radiation significantly slows down wound healing in mice.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.